Intuitive Surgical, US46120E6023

Intuitive Surgical stock: Q3 results beat expectations pre-market

Published on 10/22/2026 at 08:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The company develops robotic-assisted surgery systems and related instruments. At Lang & Schwarz the stock trades pre-market at EUR 378.43 on October 22, 2026.

Results and trading setup

  • Hargreaves Lansdown described Intuitive Surgical’s results as better than expected on October 21, 2026.
  • Intuitive Surgical held its third-quarter earnings conference call on October 20, 2026.
  • Intuitive Surgical stock trades pre-market at EUR 378.43 at 8:47 a.m. CEST at Lang & Schwarz on October 22, 2026.
Dokumentarische Schwarzweiß-Reportage aus dem OP-Saal illustriert Intuitive Surgical Inc. (US46120E6023) und den Arbeitsalltag der Chirurgie-Robotik, Illustration mit AI erstellt.

Hargreaves Lansdown reported on October 21, 2026, that Intuitive Surgical’s third-quarter results came in better than expected. Intuitive Surgical stock trades pre-market at EUR 378.43 at 8:47 a.m. CEST at Lang & Schwarz on October 22, 2026.

Results assessment

Hargreaves Lansdown said the company’s third-quarter performance benefited from broad-based revenue growth and a robust gross margin. The report also said full-year guidance was broadly unchanged, with the procedure-growth range tightened.

Ahead of the Xetra open

The latest Lang & Schwarz indication is EUR 378.43. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Intuitive Surgical stock.

The group and its market

Intuitive Surgical develops, manufactures and markets the da Vinci surgical system for robotic-assisted, minimally invasive surgery. The company’s third-quarter earnings conference call took place on October 20, 2026. Market context: Market report S&P 500.

More news and analysis on Intuitive Surgical stock

Disclaimer...
en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70391163 | bgmi